The societal value of universal childhood vaccination

被引:29
作者
Chabot, I [1 ]
Goetghebeur, MM
Grégoire, JP
机构
[1] Merck Frosst Canada Inc, Dept Hlth Econ & Outcomes Res, Kirkland, PQ, Canada
[2] BioMedCom Consultants Inc, Montreal, PQ, Canada
[3] Univ Laval, Fac Pharm, Quebec City, PQ, Canada
[4] Quebec Univ Hosp, Populat Hlth Res Unit, Quebec City, PQ, Canada
关键词
childhood vaccines; cost-effectiveness; society;
D O I
10.1016/j.vaccine.2003.10.027
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Availability of new vaccines preventing infectious diseases in healthy children populations is increasing worldwide. In Canada, despite the current recommendation of the National Advisory Committee on Immunization to include recent vaccines in routine schedule, only a few provinces have incorporated some of the newer vaccines in routine vaccination programs. A review was undertaken of economic evaluations of childhood vaccination strategies performed from the societal point of view in industrialized countries, to gain perspective on their global benefits. The general trend supports most universal vaccination programs as cost-saving or cost-effective for society. Comparison of vaccination programs with other health care interventions indicates that vaccines are often one of society's best healthcare investments. Current data suggest that the Canadian society would benefit from a more complete immunization program. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1992 / 2005
页数:14
相关论文
共 64 条
[1]  
[Anonymous], JAMA
[2]   The cost-effectiveness of routine childhood varicella vaccination in Germany [J].
Banz, K ;
Wagenpfeil, S ;
Neiss, A ;
Goertz, A ;
Staginnus, U ;
Vollmar, J ;
Wutzler, P .
VACCINE, 2003, 21 (11-12) :1256-1267
[3]   Costs and benefits of routine varicella vaccination in German children [J].
Beutels, P ;
Clara, R ;
Tormans, G ;
VanDoorslaer, E ;
VanDamme, P .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 :S335-S341
[4]   Economic evaluation of vaccination programmes -: A consensus statement focusing on viral hepatitis [J].
Beutels, P ;
Edmunds, WJ ;
Antoñanzas, F ;
De Wit, GA ;
Evans, D ;
Feilden, R ;
Fendrick, AM ;
Ginsberg, GM ;
Glick, HA ;
Mast, E ;
Péchevis, M ;
Van Doorslaer, EKA ;
van Hout, BA .
PHARMACOECONOMICS, 2002, 20 (01) :1-7
[5]   Health economics of a hexavalent meningococcal outer-membrane vesicle vaccine in children:: potential impact of introduction in the Dutch vaccination program [J].
Bos, JM ;
Rümke, HC ;
Welte, R ;
Postma, MJ ;
Jager, JC .
VACCINE, 2001, 20 (1-2) :202-207
[6]   Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox [J].
Brisson, M ;
Gay, NJ ;
Edmunds, WJ ;
Andrews, NJ .
VACCINE, 2002, 20 (19-20) :2500-2507
[7]   The cost-effectiveness of varicella vaccination in Canada [J].
Brisson, M ;
Edmunds, WJ .
VACCINE, 2002, 20 (7-8) :1113-1125
[8]   Epidemiology of varicella zoster virus infection in Canada and the United Kingdom [J].
Brisson, M ;
Edmunds, WJ ;
Law, B ;
Gay, NJ ;
Walld, R ;
Brownell, M ;
Roos, L ;
De Serres, G .
EPIDEMIOLOGY AND INFECTION, 2001, 127 (02) :305-314
[9]  
*CAN COORD OFF HLT, 1997, GUID EC EV PHARM
[10]   Estimation of direct and indirect costs because of common infections in toddlers attending day care centers [J].
Carabin, H ;
Gyorkos, TW ;
Soto, JC ;
Penrod, J ;
Joseph, L ;
Collet, JP .
PEDIATRICS, 1999, 103 (03) :556-564